
USA - NASDAQ:NBEV - US6501941032 - Common Stock
The current stock price of NBEV is 0.0935 USD. In the past month the price decreased by -64.33%. In the past year, price decreased by -94.16%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| EL | ESTEE LAUDER COMPANIES-CL A | 54.07 | 32.74B | ||
| KVUE | KENVUE INC | 15.63 | 32.09B | ||
| ELF | ELF BEAUTY INC | 25.23 | 4.42B | ||
| BRBR | BELLRING BRANDS INC | 12.76 | 3.49B | ||
| COTY | COTY INC-CL A | 18.79 | 3.12B | ||
| IPAR | INTERPARFUMS INC | 16.73 | 2.82B | ||
| EPC | EDGEWELL PERSONAL CARE CO | 7.2 | 862.76M | ||
| OLPX | OLAPLEX HOLDINGS INC | 14.25 | 760.47M | ||
| NUS | NU SKIN ENTERPRISES INC - A | 6.93 | 473.71M | ||
| NATR | NATURES SUNSHINE PRODS INC | 21.28 | 352.80M | ||
| USNA | USANA HEALTH SCIENCES INC | 9.7 | 347.31M | ||
| HNST | HONEST CO INC/THE | 42 | 280.40M |
NewAge, Inc. is engaged in the business of developing, marketing, selling, and distributing a portfolio of healthy products. The company is headquartered in Midvale, Utah and currently employs 1,127 full-time employees. The company went IPO on 2017-02-14. The firm is engaged in the development and commercialization of a portfolio of brands in three core category platforms including health and wellness, healthy appearance, and nutritional performance primarily in a direct-to-consumer. The company operates through two segments: Direct / Social Selling segment and the Direct Store segment. The Direct / Social Selling segment is focused on e-commerce and direct product sales to customers. The Direct Store segment, which is a business-to-business model, and serves traditional retail outlets in the United States including grocery retail, natural food retail, specialty outlets, hypermarkets, club stores, pharmacies, convenience stores, and gas stations. Its beverage brands include XingTea, Bucha Live Kombucha, Coco-Libre, Evian, Nestea, Illy Coffee and Volvic.
NEWAGE INC
7158 S. Flsmidth Dr, Suite 250
Midvale UTAH 80202 US
CEO: Brent Willis
Employees: 1127
Phone: 13035663030.0
NewAge, Inc. is engaged in the business of developing, marketing, selling, and distributing a portfolio of healthy products. The company is headquartered in Midvale, Utah and currently employs 1,127 full-time employees. The company went IPO on 2017-02-14. The firm is engaged in the development and commercialization of a portfolio of brands in three core category platforms including health and wellness, healthy appearance, and nutritional performance primarily in a direct-to-consumer. The company operates through two segments: Direct / Social Selling segment and the Direct Store segment. The Direct / Social Selling segment is focused on e-commerce and direct product sales to customers. The Direct Store segment, which is a business-to-business model, and serves traditional retail outlets in the United States including grocery retail, natural food retail, specialty outlets, hypermarkets, club stores, pharmacies, convenience stores, and gas stations. Its beverage brands include XingTea, Bucha Live Kombucha, Coco-Libre, Evian, Nestea, Illy Coffee and Volvic.
The current stock price of NBEV is 0.0935 USD. The price decreased by -25.2% in the last trading session.
NBEV does not pay a dividend.
NBEV has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
7 analysts have analysed NBEV and the average price target is 3.57 USD. This implies a price increase of 3718.18% is expected in the next year compared to the current price of 0.0935.
NEWAGE INC (NBEV) currently has 1127 employees.
NEWAGE INC (NBEV) has a market capitalization of 13.73M USD. This makes NBEV a Nano Cap stock.
ChartMill assigns a fundamental rating of 4 / 10 to NBEV. NBEV has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months NBEV reported a non-GAAP Earnings per Share(EPS) of -0.24. The EPS increased by 60.66% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -1.62% | ||
| ROA | -1.76% | ||
| ROE | N/A | ||
| Debt/Equity | 0.07 |
7 analysts have analysed NBEV and the average price target is 3.57 USD. This implies a price increase of 3718.18% is expected in the next year compared to the current price of 0.0935.
For the next year, analysts expect an EPS growth of 79.08% and a revenue growth 69.12% for NBEV